Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Leslie Tari | CHIEF SCIENTIFIC OFFICER | 2025-03-11 | 1,773 | $21.96 | $38.94kSell |
Shane Ward | COO CLO | 2025-03-11 | 1,664 | $21.96 | $36.54kSell |
Ra Capital Management LP | Director | 2024-11-26 | 389,716 | $14.91 | $5.81MBuy |
Taylor Sandison | Chief Medical Officer | 2024-09-11 | 924 | $11.64 | $10.75kSell |
Leslie Tari | CHIEF SCIENTIFIC OFFICER | 2024-09-11 | 909 | $11.64 | $10.58kSell |
Jeffrey Stein | President CEO | 2024-06-07 | 8,000 | $13.21 | $105.68kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Ag Mundipharma | 36.87% | 4,781,408 | $89.08M | Insider |
Target N. V. Biotech | 17.70% | 2,295,272 | $42.76M | Insider |
Nina S. Kjellson | 10.46% | 1,356,813 | $25.28M | Insider |
Bvf Inc | 8.43% | 1,092,796 | $20.36M | Institution |
Ra Capital Management LP | 8.43% | 1,092,796 | $20.36M | Insider |
Ra Capital Management LP | 8.43% | 1,092,796 | $20.36M | Institution |
Steve Elms | 8.13% | 1,054,610 | $19.65M | Insider |
Tcg Crossover Management LLC | 7.76% | 1,005,901 | $18.74M | Institution |
Vr Adviser LLC | 5.90% | 765,723 | $14.27M | Institution |
Aisling Capital II LP | 5.42% | 703,092 | $13.10M | Insider |